Literature DB >> 8647215

T cell recognition of Tn-glycosylated peptide antigens.

T Jensen1, L Galli-Stampino, S Mouritsen, K Frische, S Peters, M Meldal, O Werdelin.   

Abstract

The mouse hemoglobin-derived decapeptide Hb (67-76), VITAFNEGLK, which binds well to Ek and is non-immunogenic in CBA/J mice, was O-glycosylated with the tumor-associated carbohydrate Tn (alpha-D-N-acetylgalactosamine, or alpha-D-GalNAc). Each of the ten positions in the peptide was substituted with serine or threonine having the Tn antigen attached. The complete set of Tn-glycosylated peptides were then studied for binding to Ek and for immunogenicity in CBA/J mice. All of those glycopeptides which had the Tn attached to serine or threonine at a position in the peptide where, according to the crystal structure determinations, the amino acid side chain was oriented downwards into the binding site of the major histocompatibility complex (MHC) molecule, completely lost their capacity for binding to Ek. This was the case for the glycopeptides with Tn attached at position 68 and 76, which are the major anchor residues and for those with Tn attached at position 71 and 73, which function as secondary anchor residues. Those glycopeptides which had Tn attached to serine or threonine at positions where the side chain pointed away from the binding site maintained their capacity for binding to Ek, except for those with Tn attached at position 70 and 74. Furthermore, some of the MHC-binding glycopeptides were immunogenic. In particular, this was the case for the glycopeptide with Tn attached to the central position 72 in the decapeptide. From previous studies, this is known to be the dominant T cell receptor contact residue of Hb (67-76). The results suggest that T cells may be capable of recognizing epitopes which are partially defined by a small glycan group.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647215     DOI: 10.1002/eji.1830260625

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

1.  Processing of glycans on glycoprotein and glycopeptide antigens in antigen-presenting cells.

Authors:  Ole Werdelin; Morten Meldal; Teis Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

2.  Characterization of an immunodominant cancer-specific O-glycopeptide epitope in murine podoplanin (OTS8).

Authors:  Catharina Steentoft; Katrine T Schjoldager; Emiliano Cló; Ulla Mandel; Steven B Levery; Johannes W Pedersen; Knud Jensen; Ola Blixt; Henrik Clausen
Journal:  Glycoconj J       Date:  2010-08-19       Impact factor: 2.916

3.  Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA/1 mice.

Authors:  L K Myers; D D Brand; X J Ye; M A Cremer; E F Rosloniec; M Bodo; J Myllyharju; T Helaakoski; M Nokelainen; T Pihlajaniemi; K Kivirikko; C L Yang; L Ala-Kokko; D J Prockop; H Notbohm; P Fietzek; J M Stuart; A H Kang
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

Review 4.  Carbohydrates as T-cell antigens with implications in health and disease.

Authors:  Lina Sun; Dustin R Middleton; Paeton L Wantuch; Ahmet Ozdilek; Fikri Y Avci
Journal:  Glycobiology       Date:  2016-05-28       Impact factor: 4.313

5.  Development and characterization of an antibody directed to an alpha-N-acetyl-D-galactosamine glycosylated MUC2 peptide.

Authors:  C A Reis; T Sørensen; U Mandel; L David; E Mirgorodskaya; P Roepstorff; J Kihlberg; J E Hansen; H Clausen
Journal:  Glycoconj J       Date:  1998-01       Impact factor: 2.916

Review 6.  Bridging innate and adaptive antitumor immunity targeting glycans.

Authors:  Anastas Pashov; Bejatolah Monzavi-Karbassi; Gajendra P S Raghava; Thomas Kieber-Emmons
Journal:  J Biomed Biotechnol       Date:  2010-06-15

7.  Characterization of T cell hybridomas raised against a glycopeptide containing the tumor-associated T antigen, (betaGal (1-3) alphaGalNAc-O/Ser).

Authors:  Monika Gad; Ole Werdelin; Morten Meldal; Shiro Komba; Teis Jensen
Journal:  Glycoconj J       Date:  2002-01       Impact factor: 2.916

8.  Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants.

Authors:  R Dagan; J Eskola; C Leclerc; O Leroy
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 9.  Immunological aspects of congenital disorders of glycosylation (CDG): a review.

Authors:  Maria Monticelli; Tiago Ferro; Jaak Jaeken; Vanessa Dos Reis Ferreira; Paula A Videira
Journal:  J Inherit Metab Dis       Date:  2016-07-08       Impact factor: 4.750

Review 10.  Challenges in Antibody Development against Tn and Sialyl-Tn Antigens.

Authors:  Liliana R Loureiro; Mylène A Carrascal; Ana Barbas; José S Ramalho; Carlos Novo; Philippe Delannoy; Paula A Videira
Journal:  Biomolecules       Date:  2015-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.